Anand B Karnad

Former affiliation
  • 1227 Citations
  • 20 h-Index
1984 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Anand B Karnad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.



Hinck, A. P., Sarantopoulos, J., Curiel, T. J., Lafer, E. M., Weintraub, S. E., Karnad, A. B., Lechleiter, J. D., Thompson, I. M., Leach, R. J., Christy, B. A., Allred, C., Johnson, K., Padmanabhan, S., I-Tien, Y., Naylor, S., Gazitt, Y., Pollock, B. H., Mundy, G., Bonewald, L., Davis, S., Lee, E., Oishi, N., Hasty, E., Vijg, J. N. M. N., Herman, B. A., Johnson, K., Moyer, M., Windle, J., McGill, J., O'Connell, P., Clark, G., Kuhn, J., Wolf, R., Allred, D. C., Weiss, G., Boldt, D., Coltman, C. & Huang, H.

National Institutes of Health


Project: Research project

  • Research Output

    Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study

    Herbst, R. S., Redman, M. W., Kim, E. S., Semrad, T. J., Bazhenova, L., Masters, G., Oettel, K., Guaglianone, P., Reynolds, C., Karnad, A., Arnold, S. M., Varella-Garcia, M., Moon, J., Mack, P. C., Blanke, C. D., Hirsch, F. R., Kelly, K. & Gandara, D. R., Jan 2018, In : The Lancet Oncology. 19, 1, p. 101-114 14 p.

    Research output: Contribution to journalArticle

  • 22 Scopus citations

    Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

    Kelly, K. R., Friedberg, J. W., Park, S. I., McDonagh, K., Hayslip, J., Persky, D., Ruan, J., Puvvada, S., Rosen, P., Iyer, S. P., Stefanovic, A., Bernstein, S. H., Weitman, S., Karnad, A., Monohan, G., VanderWalde, A., Mena, R., Schmelz, M., Spier, C., Groshen, S. & 5 others, Venkatakrishnan, K., Zhou, X., Sheldon-Waniga, E., Jane Leonard, E. & Mahadevan, D., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6150-6159 10 p.

    Research output: Contribution to journalArticle

  • 7 Scopus citations

    The biology and role of CD44 in cancer progression: Therapeutic implications

    Chen, C., Zhao, S., Karnad, A. B. & Freeman, J. W., May 10 2018, In : Journal of Hematology and Oncology. 11, 1, 64.

    Research output: Contribution to journalReview article

  • 82 Scopus citations

    Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

    Fountzilas, C., Stuart, S., Hernandez, B., Bowhay-Carnes, E., Michalek, J. E., Sarantopoulos, J., Karnad, A. B., Patel, S., Weitman, S. D. & Mahalingam, D., Jan 19 2017, (Accepted/In press) In : Investigational New Drugs. p. 1-6 6 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Safety and pharmacodynamics of the PDE4 inhibitor roflumilast in advanced B-cell malignancies

    Kelly, K., Mejia, A., Suhasini, A. N., Lin, A. P., Kuhn, J., Karnad, A. B., Weitman, S. D. & Aguiar, R. C., Mar 1 2017, In : Clinical Cancer Research. 23, 5, p. 1186-1192 7 p.

    Research output: Contribution to journalArticle

  • 15 Scopus citations

    Press / Media

    San Antonio's Top Doctors 2020

    Daniel A Johnson, Steven Neish, Ruth E Berggren, Anand B Karnad, Ronald M Stewart, Scott B Johnson, John Sarantopoulos, Naveen K Mittal, Lori Pounds & Richard L Crownover


    1 item of Media coverage

    Press/Media: Press / Media

    Hematology Oncology Fellowship India

    Anand B Karnad


    1 item of Media coverage

    Press/Media: Press / Media

    New division chief named for hematology/medical oncology

    Anand B Karnad


    1 item of Media coverage

    Press/Media: Press / Media